ArticleInternational journal of molecular medicine2021

Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway.

Li Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.